ERBB2 and neoplasm: It binds to HER2 and results in inhibition of downstream signal transduction.10The HERCULES study preliminarily assessed cyclophosphamide, Herceptin, and epirubicin in MBC and announced high tumor reaction with reduced cardiotoxicity.